Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-12-15
1989-04-25
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3154
Patent
active
048248410
ABSTRACT:
The present invention relates to a process for the transformation of Piroxicam, N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1, 2-benzothiazine-3-carboxamide 1,1-dioxide into an hydrated form, suitable for oral, topic or parenteral administration.
REFERENCES:
patent: 3853862 (1974-12-01), Lombardino
patent: 4116964 (1978-09-01), Zinnes et al.
patent: 4309427 (1982-01-01), Lombardino
patent: 4434163 (1984-02-01), Lombardino
patent: 4434164 (1984-02-01), Lombardino
patent: 4628053 (1986-12-01), Fries
patent: 4636498 (1987-01-01), LaMattina
Chem. Abst. 99: 187283(d) (1983)--Van Haeringen et al.
Chem. Abst. 101: 46537(n)91984)--Bordner et al.
Chem. Abst. 101: 198023e (1984)--Bregni et al.
Textbook of Organic Chem.--Noller--1966--pp. 198-199.
Advanced Organic Chemistry--2nd ed.--Mar. pp. 804-807 (1977).
3rd Inter--Congress of Pharm. Tech.--Paris, France--1983 "Etude Des Parametres Influencant Atvitesse De Dissolution Du Piroxicame."
Lombardino et al., Journal of Medicinal Chemistry (1972), vol. 15, No. 8, pp. 848-849.
Pharmacological & Biochemical Properties of Drug Substances, vol. 3, published by American Pharm. Ass., Academy of Pharm. Sciences (1985), p. 324.
Chiesi Paolo
Pavesi Luciana
Chiesi Farmaceutici S.p.A.
Robinson Douglas W.
LandOfFree
Aqueous pharmaceutical formulations of piroxicam monohydrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous pharmaceutical formulations of piroxicam monohydrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous pharmaceutical formulations of piroxicam monohydrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1195962